In a startling revelation published during World Antimicrobial Awareness Week, researchers from the University of Plymouth disclosed that common chlorine disinfectants, widely used in hospital settings, are no longer effective against Clostridioides difficile (C. diff) spores. This superbug is a major cause of antibiotic-associated sickness globally, responsible for thousands of deaths each year in the USA and Europe alone.
The study, appearing in the journal ‘Microbiology’, demonstrates how C. diff spores can withstand even high concentrations of bleach used in hospitals. This alarming fact raises concerns about the safety of clinical environments for both healthcare workers and patients. Further, it underscores the pressing need for innovative disinfection strategies that can evolve with bacterial resistance.
At Surface Dyno, we understand the gravity of this situation and the necessity for advanced antimicrobial solutions. Our proprietary nanotechnology-based antimicrobial treatments offer a robust response to these emerging challenges. Our products, validated by EPA for effectiveness against pathogens like COVID-19, provide up to 90 days of continuous protection without contributing to antimicrobial resistance (AMR). Our non-toxic, child and pet-friendly solutions are a proactive step towards ensuring safer, germ-free environments.
In light of the increasing AMR and the limitations of traditional cleaning agents, it’s imperative to explore and adopt advanced antimicrobial technologies. Surface Dyno is committed to leading this change, offering state-of-the-art solutions to safeguard public health.
Don’t wait for an outbreak to rethink your cleanliness strategy. Contact Surface Dyno today to learn how our antimicrobial treatments can protect your facility against superbugs and create a safer environment for everyone.
